Following on from the UK NSC recommendation in January updated Prostate Cancer Risk Management Programme (PCRMP) guidance for primary care has been released in March 2016. In order to reduce variation in practice, Prostate Cancer UK have worked with health professionals across the UK to develop 13 consensus statements covering aspects including ‘baseline testing’, what to do with men at higher than average risk and who not to test – areas where the published evidence isn’t strong enough for the PCRMP to provide guidance.
In this webinar Dr Ali Cooper and Dr Jon Rees will give an overview on why and how the consensus statements were developed, how they link to the PCRMP guidance and how they aim to improve the way the PSA test is used in primary care.
Dr Jon Rees, GP with a specialist interest in urology and Dr Ali Cooper, Knowledge Manager, Prostate Cancer UK
Dr Jon Rees is a GP working in Nailsea, North Somerset, with an interest in Urology. He chairs the educational advisory group at Prostate Cancer UK, and also chairs the Primary Care Urology Society. He was a member of the guideline development group for the 2010 NICE Lower Urinary Tract Symptoms in Men guideline, and an expert advisor for the 2015 NICE prostate cancer quality standard. He helps deliver community urology services in North Somerset, Bristol & Gloucestershire, as well as Urology Advice & Guidance services for a number of CCG’s.
Dr Ali Cooper is Knowledge Manager in the Knowledge Team at Prostate Cancer UK. Prior to joining Prostate Cancer UK in May 2013, Ali worked at The Institute of Cancer Research in the Research Support team, helping researchers write grant applications and monitoring the impact of their work. Ali has a PhD in the immunology of asthma and allergy from King’s College London.